Metraipolis › archive › dc_549280fef8be

Development of a Universal In Vivo Predictive Dissolution Method for a Borderline BCS III/IV Drug Guided by Modeling and Simulations─Acyclovir as a Case Study — Europe PMC PMID:40984010

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40984010
DOI: 10.1021/acs.molpharmaceut.5c00981
License (as archived): solo-consultazione
Archived: 2026-11-09T20:02:27.732Z
SHA-256 of the archived text: 7bb4ffd9a39d9c7979e4724d61bf18f320e1ba3e8f41416d5d2922252b4bdae6
Stable URL of this page: https://metraipolis.com/documento/dc_549280fef8be

How to cite

Development of a Universal In Vivo Predictive Dissolution Method for a Borderline BCS III/IV Drug Guided by Modeling and Simulations─Acyclovir as a Case Study — Europe PMC PMID:40984010 — Europe PMC (en), https://europepmc.org/article/MED/40984010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_549280fef8be (Metraipolis archive dc_549280fef8be, sha256 7bb4ffd9a39d9c7979e4724d61bf18f320e1ba3e8f41416d5d2922252b4bdae6)

BibTeX

@misc{dc549280fef8be,
  title = {Development of a Universal In Vivo Predictive Dissolution Method for a Borderline BCS III/IV Drug Guided by Modeling and Simulations─Acyclovir as a Case Study — Europe PMC PMID:40984010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40984010},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_549280fef8be; sha256 7bb4ffd9a39d9c7979e4724d61bf18f320e1ba3e8f41416d5d2922252b4bdae6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40984010. Agents can read the archived copy with the MCP tool read_document.